Does KPV work?
No. It has only been tested in mice, and no human study exists.
For gut inflammation, the use KPV is best known for, the evidence is two mouse colitis studies and a review of the alpha-MSH peptide family. No human study of KPV has been published for any indication. 123
There are none. Kannengiesser and colleagues gave KPV to mice with two forms of colitis. The mice recovered faster and regained weight better. Tissue samples showed less inflammation. Xiao and colleagues loaded KPV into tiny particles coated with hyaluronic acid. They gave the particles by mouth, in a hydrogel, to mice with colitis. The particles protected the colon lining. They lowered the inflammatory signal TNF-alpha. They worked better than KPV particles without the hyaluronic acid coating. A 2007 review covered peptides related to alpha-MSH. It summarised anti-inflammatory effects in animals with arthritis, colitis or skin inflammation. 123
Evidence checklist
- Randomised controlled trial No human study
- Human study over 100 people No human data
- More than one research group Few groups, mouse work
- Clinical outcomes, not surrogate markers Mouse colitis scores only
- Human safety data beyond case reports No human safety data
More on KPV
Citations
- Kannengiesser 2008, Inflammatory Bowel Diseases: melanocortin-derived tripeptide KPV in murine models of inflammatory bowel disease doi.org
- Xiao 2017, Molecular Therapy: orally targeted delivery of KPV via hyaluronic acid-functionalised nanoparticles in colitis doi.org
- Luger and Brzoska 2007, Annals of the Rheumatic Diseases: alpha-MSH related peptides as anti-inflammatory and immunomodulating drugs doi.org
- FDA: July 23-24, 2026 meeting of the Pharmacy Compounding Advisory Committee fda.gov
- HHS 2026: Enforcement discretion policy regarding 503A compounding using certain peptide bulk drug substances, with appendices A and B hhs.gov
- Federal Register 2026: notice of availability of the HHS peptide enforcement discretion policy, document 2026-22192, docket HHS-OASH-2026-0496 federalregister.gov
- Associated Press via CNN, 28 October 2026: FDA scientists opposed the move to ease peptide access edition.cnn.com
Reference information only, not medical advice. Drawn from the KPV article, fact-checked against the cited sources. No dosing anywhere on this site.